A sequential injection analysis (SIA) system for the determination of total calcium in blood has been implemented. The assay principle is based on the arsenazo III method, in which the indicator's complex with calcium forms a blue-purple colour. The absorbance peak height at 650 nm was proportional to the calcium content in samples. A linear range was obtained from 2.5 -15 mg·dL -1 (r 2 = 0.999), with a detection limit of 0.430 mg·dL -1 (3σ). Magnesium, glucose, haemoglobin, and bilirubin at 123, 1,000, 50, and 0.5 mg·dL -1 , respectively, were not found to interfere with the proposed system significantly (recovery 99.1% -104.4%). The sampling frequency was 30 h -1 , in which the carry-over effect was negligible (0.69%). The proposed SIA system was successfully applied to the determination of calcium from serum samples (r 2 = 0.970; n = 30).
Introduction
Blood calcium is distributed among several forms, of which the major forms are free calcium ions and proteinbound calcium. Calcium content is closely associated with a large number of diseases, such as hypo-and hyperthyroidism, acute pancreatitis, malignancy, and vitamin D deficiency [1] . Thus, many researchers have turned their attention to developing quantitative measurements of calcium levels in serum specimens because of the potential for diagnosing these disorders. Until recently, improvements in alternative approaches for assaying calcium depended heavily on the types of calcium found in blood circulation.
The use of ionised calcium, a useful marker for assessing calcium regulation disorders, makes the accurate interpretation of results difficult due to the effects from maintaining pH levels that rely on the carbon dioxide content of the samples [2] . In contrast, the determination of total calcium ions is more popular and widely used in most clinical laboratories because of its simplicity of operation. The methods based on dye-binding, such as o-cresolphthalein complexone and arsenazo III, are commonly used for determining total blood calcium. Considering a dye that specifically forms a complex with calcium, arsenazo III can be simply prepared and used without the addition of 8-hydroxyquinoline, a potential magnesium masking reagent [3] . It offers an advantage over other dye-binding methods that require a separate reagent preparation.
Currently, numerous approaches for quantifying the amount of calcium based on arsenazo III have been reported, such as the spectrophotometric method [3,4], microfluidic-based platforms [5] [6] [7] , flow injection analysis [8] [9] [10] , and sequential injection analysis (SIA) [11, 12] . The preceding studies on the determination of calcium by means of SIA system have been applied and validated, but solely for the environmental samples, no utility being expressed for the complex biological samples. In regard to clinical assessment, the ability to make rapid measurements has become the cornerstone of serum calcium assays. Owing to an anaerobic metabolism of blood cells, the specimens should be handled and analysed promptly. The alteration of sample pH can affect calcium levels; therefore, an analysis should be completed within 1 hour [2] . Typically, turnaround time is of considerable importance in batch processing, thereby utilizing SIA is an alternative approach to analytical systems. With the proposed SIA technique, it is well-known in terms of its fully automatic operation, simple sampling procedure, high throughput of samples, low reagent consumption, inexpensive instrumentation, and short analysis time [13] . Unless otherwise stated, SIA is appropriate for the overwhelming majority of clinical laboratories for monitoring calcium status at a patient's bedside due to its fast processing and great precision.
Although calcium quantification using SIA has previously been reported in conjunction with the o-cresolphthalein complexone reaction [14] [15] [16] , the use of arsenazo III for serum calcium determination has yet to be investigated. For this reason, we proposed here a simple, rapid, and greener analytical procedure for real sample analysis of total serum calcium. Using this configuration of SIA, we obtained excellent accuracy and reproducibility for this calcium assay.
Materials and Methods

Reagents and Chemicals
Analytical grade chemicals were used in this study. For the calcium standard, calcium carbonate was supplied by Mallinckrodt (St. Louis, USA). Arsenazo III and bilirubin were purchased from Fluka (Buchs, Switzerland). Piperazine-N,N'-bis[2-ethanesulfonic acid (PIPES), 2-(N-morpholino)ethanesulphonic acid (MES), haemoglobin, magnesium sulphate, and D-glucose were acquired from Sigma (St. Louis, USA). Hydrochloric acid was purchased from Merck (Darmstadt, Germany). Taking into account method validation, calcium assay kits from Randox Laboratories (Crumlin, United Kingdom) were used for a comparison study. To obtain varying calcium levels in samples, two levels of control serums (Liquid Assayed Multiqual®) from Bio-Rad Laboratories (Berkeley, USA) were used to spike in real serum samples.
For the preparation of calcium stock standards (200 mg·dL -1 ), five grams of dried calcium carbonate were dissolved in 1 M hydrochloric acid and diluted to 1 L with Milli-Q water (Millipore, USA).
Apparatus
The proposed system ensured the configuration of the SIA method, including a syringe pump (Cavro XL 3000, Cavro Scientific Instruments Inc., USA) equipped with a 2.5 mL syringe, a multi-position selection valve (Cavro Smart Valve, Cavro Scientific Instruments Inc., USA), and a spectrophotometric detector (Evolution 600, Thermo Scientific, USA) incorporated with an 18 μL quartz flowthrough cell. The system is depicted in Figure 1 . Each absorbance peak height was recorded and assessed with commercial software. PTFE tubing with 0.8 mm i.d. (Cole-Palmer Instrument Company, USA) was used to connect the different components of the flow system, and all connectors used were made of PEEK (Upchurch Scientific, USA). The conventional arsenazo III, a batch cuvette-based method, was performed using the same UV-VIS spectrophotometer mentioned above, according to the protocol described in the instruction manual provided by Randox Laboratories.
Procedure
Unless otherwise stated, the whole operating sequence of the SIA system for quantitative calcium analysis is revealed in Table 1 . The system began by aspirating the carrier buffer into syringe. The arsenazo III and standard/sample solutions then followed the carrier buffer into the holding coil, and the arsenazo III reagent was subsequently aspirated again. The flow direction was then reversed, resulting in the displacement of the reaction mixture to the flow-through cuvette. Using the spectrometric detector, the chemical reaction between arsenazo III and calcium was quantified at 650 nm as a result of its blue-purple complex. To avoid contamination from other substances, a solution of 1 M hydrochloric acid was injected into the SIA system and subsequently washed with the carrier buffer.
Results and Discussion
Optimum Performance of Calcium Assay
Operation Sequence
Preliminary results demonstrated that 200 µL arsenazo III reagent was particularly suitable for interacting with 10 µL calcium. Thus, we intended to select a reagent/ sample ratio of 200:10. According to Figure 2 (a), the aspiration sequence was optimised by studying four variants of the aspiration sequence. The operation sequence 2 (SQ-2) gave the highest analytical signal when evaluated with 5 and 15 mg·dL -1 calcium, as shown in Figure 2 (b). For this reason, the aspiration sequence of arsenazo III reagent (100 μL), sample (10 μL), and arsenazo III reagent (100 μL) was selected for further studies. 
Sample Volume
To study the effect of sample volumes, the arsenazo III reagent was fixed at 200 µL, in which 100 µL was aspirated while sandwiched between various sample volumes ranging from 5 to 75 µL. As shown in Figure 3 , the results demonstrated that the peak height signal increased with an increase in sample volume. However, when tested with high calcium concentration (15 mg·dL -1 ), the increase in sample volume did not obviously influence the analytical signals. Peak height curve reached a plateau while injecting a volume higher than 10 μL. In addition, the use of 10 μL sample volume gave a wider linear range than that of other volumes. Therefore, the sample volume of 10 μL was chosen for further experiments.
Effect of Arsenazo III Concentration
Taking into account of different variables in determination of calcium, the reagent concentration is one of the most significant factors in calcium assay. In this study, the operation sequence of aspirating the arsenazo III reagent (100 μL), sample (10 μL), and arsenazo III reagent (100 μL) was used as a model to study the effect of arsenazo III concentration. The effect of increasing arsenazo III concentration on absorbance sensitivity was investigated in the range of 50 -400 µM. As shown in Figure 4 , the analytical signals of the four different concentrations of arsenazo III were compared. The results demonstrated that the sensitivity increased with an increasing arsenazo III concentration. Hence, an arsenazo III concentration of 400 µM was selected for all subsequent experiments because it provided a wider linearity, and up to 15 mg·dL -1 of calcium could be assayed. The normal reference range for total calcium in adults is approximately 8.6 to 10.3 mg·dL -1 [2] . The proposed assay is therefore able to detect the concentration of total calcium covering the entire clinical range.
Carrier Buffer and Flow Rate
At an alkaline pH, arsenazo III reacts with magnesium, a divalent cation found in blood, thus reducing the specificity of assay performance. The hydroxyquinoline-5-sulphonic acid (8HQS) was needed as a masking agent in the alkaline reagent [17] . Although an alkaline pH region provides the greater sensitivity than acidic region, we decided on an acidic pH as a reagent to avoid the use of 8HQS. In acidic range, it still maintains the adequate sensitivity to determine serum calcium and provides a wide linearity covering the reference interval and pathological range. Thus, the effect of sample dilution upon the assay is almost negligible. In the preliminary studies, two types of buffers, PIPES and MES, were investigated at a pH of 6.5. The results demonstrated that the use of 25 mM PIPES buffer gave better assay signals than using 25 mM MES buffer at the same pH (data not shown). Therefore, PIPES buffer was the buffer of choice for our study. In addition, three different concentrations of PIPES were also studied with 3 levels of standard calcium, which were 5, 10, and 15 mg·dL -1 . As shown in Figure 5 , the increasing concentration of PIPES provided the decrease in assay signal. The highest sensitivity was obtained with 25 mM PIPES buffer; therefore, this concentration was chosen for further experiments.
Furthermore, the study on flow rates of the carrier buffer was under investigation for absorbance sensitivity. After completing in dye binding reaction, the calciumarsenazo III complex was dispersed to spectrophotometric detector with the constant flow rates ranging from 15 µL·s -1 to 35 µL·s -1 . According to Figure 6 , the effect of five different flow rates on absorbance signals was compared. Considering at a steady flow rate of 25 µL·s -1 , the results displayed that it provided the highest response signal, thereby being selected for further experiments. 
Analytical Characteristics
Analytical Curve and Limit of Detection
·
The absorbance peak height of the calcium standards and a typical analytical curve are shown in Figure 7(a) . Linear relationships between the absorbance peak heights and concentrations of calcium were observed from 2.5 to 15 mg·dL -1 with correlation coefficients of 0.999, as shown in Figure 7(b) . The detection limit assessed by the signal-to-noise ratio of 3 was 0.430 mg·dL -1 , or 0.107 mM. This implies that the sensitivity of our proposed SIA system is slightly more sensitive than the method described previously by J. Nyman et al. [15] . Based on the o-cresolphthalein complexone-based SIA approach, their detection limit is maximised at 0.125 mM. However, the SIA method described here is less sensitive than our previous microfluidic-based technique [5] . Nevertheless, the SIA method was more advantageous than the microfluidic platform, in terms of high throughput analysis.
Although there have been several reports describing the versatility of the SIA system for analysis of environmental calcium in water and food [15, 16, 18, 19] , until now, very few papers have exploited the SIA system for calcium determination in real clinical samples. Staden et al. [14] proposed the SIA system for determination of calcium in water, urine, and pharmaceutical samples based on the o-cresolphthalein complexone method. However, its analytical curve was linear between 0 and 2 mg·dL -1 , which is narrower than our SIA system by a factor of approximately 7.5. Our proposed SIA system covers the broad linear range, thereby eliminating the need to dilute serum samples prior to analysis.
Precision, Reproducibility, and Sample
Frequency The reproducibility of the method was investigated with 20 runs of 10 mg·dL -1 and 15 mg·dL -1 calcium on the same day. The results demonstrated that within-run reproducibility was observed at 1.3% and 1.2% CVs for 10 mg·dL -1 and 15 mg·dL -1 calcium, respectively. Furthermore, the results of four analytical curves constructed on different consecutive days revealed good reproducibility, in which within-run CVs from 0.7% -1.7% and run-torun CVs of 2.6% were obtained.
According to the high-throughput, our proposed SIA system could process up to 30 runs per hour.
Carry-Over Effect
The carry-over effect between consecutive samples was determined by first analysing a sample containing a high analyte concentration (15 mg·dL -1 calcium) in triplicate, followed by analysing a sample with a low analyte concentration (2.5 mg·dL -1 calcium) in triplicate. The carryover effect was investigated following a method described by Haeckel et al. [20] . With our method, the carry-over effect was calculated to be 0.69%, which is negligible. Because the acid wash step was included in the running protocol, a low carryover effect between run was achieved.
Interferences
The interference effects on the determination of calcium from foreign substances that commonly exist in blood samples were investigated. With the aim of studying assay specificity, calcium recovery tests were carried out in the presence of other substances. Control serums (calcium ~ 9.8 mg·dL -1 ) containing specified concentrations of each substance were injected into the SIA system, and the absorbance peak heights were compared with those obtained from the presence of control serum alone. As shown in Table 2 , the results implied that the interferences from common components in serum such as magnesium (123 mg·dL ) were acceptable, with recoveries between 99.1% -104.4%. 
Method Comparison
Clotted blood samples were centrifuged at 1500 g for 15 min in order to separate the serum. In our experiment, several levels of assay samples, including those with lower and higher than normal calcium levels, were obtained by spiking the real serum samples with various levels of calcium from the commercial control serums. Thirty samples were subjected to the arsenazo III SIA system for determination of calcium and compared with the results of current large-scale spectrophotometric methods. In practically, it was not necessary to dilute the actual samples from patients with saline prior to analysis, because of the rather broad linearity of our proposed system, which ranges from 2.5 to 15 mg·dL -1 of calcium. A scatter plot of the results obtained from both methods is shown in Figure 8 included the ideal value of zero, indicating that the intercept was not significantly different from 0 at the 0.05 alpha level (p value = 0.526). The slope of graph was 0.979 with a 95% confidence interval of 0.913 -1.045, suggesting that the slope was not significantly different from 1 because this range included the model value of 1.0. With 95% confidence interval and degree of freedom of 28, the critical t-value (t 0.05, 28 ) was calculated to be ±2.048. Paired sample statistical analysis revealed that the experimental value of |t| was 0.092, a significantly lower than the critical t-value so the null hypothesis assumed no differences in means between the results of the two methods. These data suggest that the arsenazo II SIA system highly correlates with the conventional spectrophotometric method that utilises an assay kit from Randox (p-value < 0.05).
Conclusion
A simple spectrophotometric SIA system for rapid determination of serum calcium has been implemented. Major advantages of the proposed system include lower arsenazo III reagent consumption and a relative throughput of 30 runs per hour. The proven low carry-over effect and the high correlation to the conventional method demonstrate the applicability of the SIA system for real serum sample analysis. In other words, the proposed SIA system has become the method of choice for clinical routine assay because it is easy to perform and offers an accurate interpretation at clinically significant levels.
